TGFB1 and cancer: Interestingly, poor prognosis in CRC patients with a stem/serrated/mesenchymal (SSM) subtype was recently linked to the activation of TGFβ signaling within cancer-associated fibroblasts (CAFs), which increased the frequency of tumor-initiating cells and the promotion of metastatic invasion in humanized mouse models50,51.